“The Company owns MANF composition of matter pat
Post# of 30028
(Total Views: 432)
Posted On: 12/26/2017 9:52:57 AM
“The Company owns MANF composition of matter patents and patent applications in the United States and Europe. It also owns, or has acquired exclusive rights to, US and international patents and patent applications covering the therapeutic use of MANF in the treatment of retinal disorders, beta cell disorders, Parkinson's disease, and several other diseases.”
This ftom todays PR I’m sure is in response to some doubts on Manf Patents
This ftom todays PR I’m sure is in response to some doubts on Manf Patents
(6)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼